匹多莫德治疗小儿反复下呼吸道感染的疗效及对患儿免疫功能的影响.docVIP

匹多莫德治疗小儿反复下呼吸道感染的疗效及对患儿免疫功能的影响.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
匹多莫德治疗小儿反复下呼吸道感染的疗效及对患儿免疫功能的影响.doc

匹多莫德治疗小儿反复下呼吸道感染的疗效及对患儿免疫功能的影响   [摘要] 目的 探讨匹多莫德治疗小儿反复下呼吸道感染的疗效及对患儿免疫功能的影响。方法 方便选取2014年6月―2015年1月于该院就诊的小儿反复下呼吸道感染患儿共50例,将患儿按照入院编号随机分为两组,观察组和对照组患儿各25例,采取常规方式来给对照组患儿进行治疗;而对观察组患儿的治疗,则是在对照组的基础之上,再使用匹多莫德进行治疗,两组患儿在接受为期2个月的治疗后,比较两组患儿的治疗效果。结果 在经过2个月的治疗后,观察组25例患儿的治疗总有效率为92%,要明显优于对照组的52%;两组患儿治疗后,免疫功能的各项指标均得到了有效地改善,且观察组免疫功能的各项指标改善情况明显要比对照组的情况好,比较差异有统计学意义(P0.05)。结论 使用匹多莫德治疗小儿反复呼吸道感染,能够有效的提高患儿治疗效果,减少患儿的呼吸道感染复发次数,且患儿免疫功能的各项指标也得到了明显的改善,具有非常理想的治疗效果,值得在临床上大力推广。   [关键词] 匹多莫德;呼吸道感染;免疫功能   [中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2016)04(c)-0140-03   [Abstract] Objective To discuss the curative effect of pidotimod in treatment of repeated lower respiratory tract infection in children and effect of it on the immunologic function of children. Methods 50 cases of children with repeated lower respiratory tract infection diagnosed in our hospital from June 2014 to January 2015 were selected and randomly divided into two groups with 25 cases in each according to the admission order, the control group were treated with the conventional method, the observation group were treated with additional pidotimod on the basis of the control group, and the treatment effects were compared between the two groups after 2 months of treatment. Results After 2 months of treatment, the total treatment effective rate in the observation group was obviously better than that in the control group, (92% vs 52%), the various indexes of immunologic function were effectively improved, and the improvement of various indexes of immunologic function in the observation group was obviously better than that in the control group, and the comparison had obvious differences with statistical significance, P0.05. Conclusion Pidotimod in treatment of repeated lower respiratory tract infection in children can effectively improve the treatment effect and reduce the recurrence times of respiratory tract infection of children and the various indexes of immunologic function of children are obviously improved, and it has a very idea

文档评论(0)

ganpeid + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档